Skip to content
DataLookout
Menu

NCT05683886

A Study of KC1036 in Patients with Advanced Thymic Tumors

StatusUnknown
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
  2. Minor Site contacts updated at 2 of 2 sitesv3
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 2023 to Feb 22, 2023
    • Site details revised at 2 of 2 sites
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Objective Response Rate (ORR)
Timeframe: approximately 2 year

Secondary (4)

Progression-free survival (PFS)
Disease Control Rate (DCR)
Duration of Response (DOR)
Adverse events (AEs)

Arms and interventions

KC1036Experimental

60mg QD

Drugs: KC1036

Sites

2 sites in 1 country